Finally, we rescued the decreased ovarian function in the M group by blocking the CXCL10 IL18R1 pathway with CXCL10 antibody or a CXCL10IL18R1 interface peptide, CIBB
Departments of Agriculture and Health and Human Services | AAFP, accessed April 22, 2025, Healthy diet - World Health Organization (WHO), accessed April 22, 2025, 2015-2020 Dietary Guidelines for Americans - Office of the Assistant Secretary for Health, accessed April 22, 2025, Muscle Mass and Glucagon-Like Peptide-1 Receptor Agonists: Adaptive or Maladaptive Response to Weight Loss
The mechanisms are fundamentally different, producing effects at different scales
Despite being very efficacious, the androgenic side effects are considerable and irreversible